Study Records. On behalf of Principal Investigator and itself, Institution will retain each Study Subject’s Study records, which include the Principal Investigator’s copies of all Study Data as well as relevant source documents (collectively, “Study Records”), under storage conditions conducive to their stability and protection, for a period of 15 years after termination of the Study unless CRO or Pfizer authorizes, in writing, earlier destruction. Institution agrees to contact Pfizer at prior to destroying any Study Records and Principal Investigator and Institution further agree to permit Pfizer to ensure that the Study Records are retained for a longer period if necessary, at Pfizer’s expense, under an arrangement that protects the confidentiality of the records (e.g., secure off-site storage).
Appears in 2 contracts
Study Records. On Institution, on behalf of Principal Investigator and itself, Institution will retain each Study Subject’s Study records, which include the Principal Investigator’s copies of all Study Data as well as relevant source documents (collectively, “Study Records”), under storage conditions conducive to their stability and protection, for a period of 15 years after termination of the Study unless CRO or Pfizer authorizes, in writing, earlier destructionStudy. Institution agrees to contact Pfizer at prior ████████████████prio r to destroying any Study Records and Principal Investigator and Institution further agree agrees to permit Pfizer to ensure that the Study Records are retained for a longer period if necessary, at Pfizer’s expense, under an arrangement that protects the confidentiality of the records (e.g., secure off-site storage).
Appears in 1 contract
Sources: Clinical Study Agreement
Study Records. On behalf of Principal Investigator and itself, Institution will retain each Study Subject’s Study records, which include the Principal Investigator’s copies of all Study Data as well as relevant source documents (collectively, “Study Records”), under storage conditions conducive to their stability and protection, for a period of 15 years after termination of the Study unless CRO or Pfizer authorizes, in writing, earlier destruction. Institution agrees to contact Pfizer at prior to destroying any Study Records and Principal Investigator and Institution further agree to permit Pfizer to ensure that the Study Records are retained for a longer period if necessary, at Pfizer’s expense, under an arrangement that protects the confidentiality of the records (e.g., secure off-site storage).
Appears in 1 contract
Sources: Clinical Study Agreement
Study Records. On Institution, on behalf of Principal Investigator and itself, Institution will retain each Study Subject’s Study records, which include the Principal Investigator’s copies of all Study Data as well as relevant source documents (collectively, “Study Records”), under storage conditions conducive to their stability and protection, for a period of 15 years after termination of the Study unless CRO or Pfizer authorizes, in writing, earlier destruction. Institution agrees to contact Pfizer at ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇.▇▇▇ prior to destroying any Study Records and Principal Investigator and Institution further agree agrees to permit Pfizer to ensure that the Study Records are retained for a longer period if necessary, at Pfizer’s expense, under an arrangement that protects the confidentiality of the records (e.g., secure off-site storage).
Appears in 1 contract
Sources: Clinical Study Agreement
Study Records. On behalf of Principal Investigator and itself, Institution Provider will retain each Study Subject’s Study records, which include the Principal Investigator’s copies of all Study Data as well as relevant source documents (collectively, “Study Records”), under storage conditions conducive to their stability and protection, for a period of 15 years after termination of the Study unless CRO or Pfizer authorizes, in writing, earlier destruction. Institution Provider agrees to contact Pfizer at prior to destroying any Study Records records and Principal Investigator and Institution Provider further agree to permit Pfizer to ensure that the Study Records records are retained for a longer period if necessary, at Pfizer’s Pfizer expense, under an arrangement that protects the confidentiality of the records (e.g., secure off-site storage).
Appears in 1 contract
Sources: Clinical Study Agreement